Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 44, n° 2P2
pages 336-338 (février 2001)
Doi : 10.1067/mjd.2001.102668
Treatment of porphyria cutanea tarda with phlebotomy in a patient on peritoneal dialysis

Maureen A. Kelly, MD, Katherine D. O'Rourke, MD
Department of Dermatology, Wake Forest University School of Medicine. Winston-Salem, North Carolina 


Porphyria cutanea tarda (PCT) is frequently described among patients with chronic renal failure undergoing hemodialysis. One patient who was receiving peritoneal dialysis and had PCT develop has been described in the literature. However, it was later determined that the patient's PCT was related to the hepatotoxic drug she was receiving rather than her peritoneal dialysis. Our patient is the first reported case, to our knowledge, of a patient with end-stage renal disease with negative hepatitis serology who was not receiving a hepatotoxic drug, or on hemodialysis, who had PCT develop while receiving peritoneal dialysis. (J Am Acad Dermatol 2001;44:336-8.)

The full text of this article is available in PDF format.

 This supplement is made possible through an educational grant from Ortho Dermatological to the American Academy of Dermatology.
 Reprint requests: Katherine D. O'Rourke, MD, Department of Dermatology, Medical Center Blvd, Winston-Salem, NC 27157-1071.
 J Am Acad Dermatol 2001;44:336-8

© 2001  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@